Format

Send to

Choose Destination
Mol Cancer Res. 2019 Jul;17(7):1493-1502. doi: 10.1158/1541-7786.MCR-18-1045. Epub 2019 Apr 9.

Characterization of HCC Mouse Models: Towards an Etiology-Oriented Subtyping Approach.

Author information

1
Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland.
2
Swiss Hepato-Pancreato-Biliary Center, Department of Digestive and Transplant Surgery, University Hospital of Zurich, Zurich, Switzerland.
3
Helmholtz Zentrum München Research Center for Environmental Health (GmbH), Research Unit Radiation Cytogenetics.
4
Department of Pathology, University of California, San Diego, California.
5
Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
6
Division Chronic Inflammation and Cancer, German Cancer Research Center, Heidelberg, Germany. achim.weber@usz.ch m.heikenwaelder@dkfz.de.
7
Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland. achim.weber@usz.ch m.heikenwaelder@dkfz.de.

Abstract

Murine liver tumors often fail to recapitulate the complexity of human hepatocellular carcinoma (HCC), which might explain the difficulty to translate preclinical mouse studies into clinical science. The aim of this study was to evaluate a subtyping approach for murine liver cancer models with regard to etiology-defined categories of human HCC, comparing genomic changes, histomorphology, and IHC profiles. Sequencing and analysis of gene copy-number changes [by comparative genomic hybridization (CGH)] in comparison with etiology-dependent subsets of HCC patients of The Cancer Genome Atlas (TCGA) database were conducted using specimens (75 tumors) of five different HCC mouse models: diethylnitrosamine (DEN) treated wild-type C57BL/6 mice, c-Myc and AlbLTαβ transgenic mice as well as TAK1LPC-KO and Mcl-1Δhep mice. Digital microscopy was used for the assessment of morphology and IHC of liver cell markers (A6-CK7/19, glutamine synthetase) in mouse and n = 61 human liver tumors. Tumor CGH profiles of DEN-treated mice and c-Myc transgenic mice matched alcohol-induced HCC, including morphologic findings (abundant inclusion bodies, fatty change) in the DEN model. Tumors from AlbLTαβ transgenic mice and TAK1LPC-KO models revealed the highest overlap with NASH-HCC CGH profiles. Concordant morphology (steatosis, lymphocyte infiltration, intratumor heterogeneity) was found in AlbLTαβ murine livers. CGH profiles from the Mcl-1Δhep model displayed similarities with hepatitis-induced HCC and characteristic human-like phenotypes (fatty change, intertumor and intratumor heterogeneity). IMPLICATIONS: Our findings demonstrate that stratifying preclinical mouse models along etiology-oriented genotypes and human-like phenotypes is feasible. This closer resemblance of preclinical models is expected to better recapitulate HCC subgroups and thus increase their informative value.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center